CHEN-HUA LIUPeng, Cheng-YuanCheng-YuanPengKao, Wei-YuWei-YuKaoYang, Sheng-ShunSheng-ShunYangShih, Yu-LuengYu-LuengShihCHIH-YUAN LEEMENG-KUN TSAILee, Chih-YuanChih-YuanLeeChang, Chun-ChaoChun-ChaoChangWu, Jo-HsuanJo-HsuanWuCHUN-JEN LIUTUNG-HUNG SUTAI-CHUNG TSENGPEI-JER CHENJIA-HORNG KAO2022-09-292022-09-292022-020269-2813https://scholars.lib.ntu.edu.tw/handle/123456789/623264Data are limited regarding the risk of hepatitis C virus (HCV) reinfection after treatment-induced sustained virologic response (SVR) in patients on haemodialysis.enTREATMENT-NAIVE PATIENTS; LOW-DOSE RIBAVIRIN; PEGINTERFERON ALPHA-2A; RECEIVING HEMODIALYSIS; PEGYLATED INTERFERON; WEEKS POSTTREATMENT; INFECTION; RISK; HCV; ELIMINATION[SDGs]SDG3Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatmentjournal article10.1111/apt.16697347732722-s2.0-85118917578WOS:000717941000001https://scholars.lib.ntu.edu.tw/handle/123456789/619206